SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending due to community discussion around earnings and a subsequent price dip, with debates focusing on valuation and the influence of Michael Burry's short position. Some are optimistic about a rebound, citing AI hype and strong fundamentals, while others express concern about overvaluation and potential downside. CEO Alex Karp's remarks about shorts on CNBC are also fueling discussion.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as the community rallies around the OG meme, emphasizing retail unity and a return to the values that built the internet. Discussions focus on the power of community, conviction, and the potential for a cultural reset in the crypto space. Believers are expressing enthusiasm and long-term commitment, anticipating a potential moonshot.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

HTZ is trending due to positive earnings news and potential short squeeze, sparking bullish sentiment. The community is discussing whether HTZ could become the next meme stock with high short interest and a possible squeeze fueled by retail investors. Some are comparing the stock's turnaround to Carvana's and anticipating a climb to double digits.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending due to reports of a potential White House deal to expand Medicare coverage for obesity drugs, which could significantly increase access to their GLP-1 medications. While some investors are excited about the expanded market, others worry about potential price caps and increased competition from Eli Lilly and Pfizer. Community chatter revolves around whether this news will reverse the stock's recent downward trend, with some seeing it as a buying opportunity.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

UBER is trending as investors digest mixed signals post-earnings, balancing strong performance metrics with concerns about guidance and broader market conditions. Community discussions revolve around whether the dip represents a buying opportunity, with some highlighting the potential for long-term growth driven by autonomous vehicle initiatives. Several analysts have reiterated Buy ratings, noting robust growth, while others observe that the stock price has been disconnected from fundamentals.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Despite positive revenue figures, SRPT is trending down as investors react to news regarding its PMO therapies and guidance. The community is actively discussing the potential for a buyout, short covering, and the future of Elevidys. Overall sentiment seems mixed, with some viewing the dip as a buying opportunity while others express concern over management and future prospects.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

$SLAP is trending amidst community enthusiasm, with many highlighting the project's strong community and potential. Active discussions revolve around staking and IRL partnerships, as well as positive sentiment towards the team's efforts. The crypto community is rallying behind the token, emphasizing a shared vision and collective success.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending amid discussions around its pursuit of Metsera and competition with Novo Nordisk in the obesity drug market, as well as an upcoming earnings report and dividend payout. The community is focused on the potential impact of the Metsera acquisition and whether Pfizer can maintain its competitive edge. Some traders are eyeing potential breakouts while others express frustration with the stock's historical performance.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG is trending as community members highlight its strong ties to the Bitcoin network and its fair distribution via airdrop. Discussion centers on $DOG being the premier meme coin on Bitcoin and the growing $DOG army. The connection between $DOG and $CBLO, a public company accumulating $DOG, is also a key talking point.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending as investors discuss the recent rise in share price, with some attributing the jump to updated revenue guidance and others speculating about analyst upgrades or a potential buyout. Community members are actively debating the impact of the updated revenue guidance and potential motivations behind analyst inquiries regarding AUR200, with some hoping for a patent extension.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Energy Fuels (UUUU) Reports Q3 Loss, Tops Revenue Estimates

Energy Fuels (UUUU) delivered earnings and revenue surprises of +12.50% and +79.80%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

<ul class="summary-bullets"><li>U.S. Antimony raised its fiscal 2026 revenue forecast to $125 million, sending shares up over 18% in premarket trading.</li><li>The company’s Montana mining restart and U.S.–China rare earth agreements boosted retail interest.</li><li>The company has staked more than 100 federal claims around Stibnite Hill to secure additional resources.</li></ul>United States Antimony Corp. (UAMY) on Thursday preliminarily raised its fiscal 2026 revenue forecast by $25 million to $125 million, more than double the 2025 revenue outlook of $40 million - $50 million.&nbsp;Following the update,&nbsp;<a href="https://stocktwits.com/symbol/UAMY">U.S. Antimony stock</a> traded over 18% higher in Thursday’s premarket and was among the top three trending equity tickers on Stocktwits. Retail sentiment around the stock remained in ‘bullish’ territory amid ‘high’ message volume levels.&nbsp;<h2 class="st-heading-2">Mining In Stibnite Hill</h2>The increase in projected revenue follows the company's announcement that it would resume extraction activities at the Stibnite Hill site in Montana.&nbsp;Also providing a thrust to the stock was U.S. President Donald Trump and Chinese President Xi Jinping’s&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rare-earth-stocks-in-spotlight-after-trump-xi-agree-to-critical-minerals-deal/cLGFNAUR3DN">meeting</a>, which yielded new agreements aimed at stabilizing the global supply of rare earth minerals. Both countries have agreed to implement an annual deal governing rare earth exports, which will be renegotiated each year upon renewal. The development eased some concerns over access to critical minerals.According to the company, the renewed operation centers on advanced surface mining methods to access antimony deposits that were previously uneconomical to mine.&nbsp;The new “cut and cover” approach utilizes hydraulic excavators and reclamation-friendly sequencing, reducing the need for extensive infrastructure.<h2 class="st-heading-2">Operational Progress and Early Output</h2>The Montana Department of Environmental Quality approved USAC’s updated mining plan on October 2, 2025. Just days later, the company began a mechanized bulk sampling program, hauling its first truckloads of high-grade stibnite ore by October 8.&nbsp;The company has staked more than 100 federal claims around Stibnite Hill to secure additional resources and is in discussions to acquire adjacent patented claims.United States Antimony stock has gained over 374% in 2025 and over 1,212% in the last 12 months.&nbsp;Also See:<a href="https://stocktwits.com/news-articles/markets/equity/etsy-names-kruti-patel-goyal-as-next-ceo-stock-slides-on-lower-sales-outlook/cLGZYvuR3w8">&nbsp;</a><a href="https://stocktwits.com/news-articles/markets/equity/what-s-fueling-the-big-rally-in-us-antimony-stock-today/cLGFubdR3xI">What’s Fueling The Big Rally In US Antimony Stock Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the United States Antimony (US Antimony) logo is seen displayed on a smartphone screen

What’s Fueling The Big Rally In US Antimony Stock Today?

U.S. Antimony raised its fiscal 2026 revenue forecast to $125 million, sending shares up over 18% in premarket trading.

Equity

U.S. Antimony’s Montana mining restart and U.S.–China rare earth agreements boosted retail interest.


<ul class="summary-bullets"><li>The Australian miner said that the offer materially undervalued the company.</li><li>The initial offer included a fixed exchange ratio of 6 UAMY common stock shares for every 100 Larvotto shares.</li><li>Larvotto’s Hillgrove project is expected to meet 7% of the world’s antimony demand upon full commissioning.</li></ul>Australia’s Larvotto Resources rejected a buyout offer by the United States Antimony Corp (UAMY) on valuation concerns.The American miner unveiled an offer earlier this month to pay Larvotto shareholders A$1.40 per share to acquire the remaining shares it does not own. U.S. Antimony already disclosed a 10% stake in the Australian miner before the offer.<h2 class="st-heading-2">Why Did Larvotto Reject UAMY’s Deal?</h2>The Australian miner said the offer materially undervalued the company. The board took the decision after the implied offer value slipped to A$1.13 per Larvotto share from A$1.40, based on UAMY’s 5-day volume weighted average price to Oct. 24. The initial offer included a fixed exchange ratio of 6 UAMY common stock shares for every 100 Larvotto shares.“The Board is confident that Larvotto’s intrinsic value and long-term growth potential significantly exceed the indicative value implied by the Offer,” Mark Tomlinson, Larvotto’s non-executive chair, said.The company said it remains focused on its Hillgrove gold and antimony project, which is on track to achieve first production in 2026. “At current gold and antimony prices, the project’s capital payback is expected to be achieved within months of first production,” Tomlinson added.<h2 class="st-heading-2">Why Was UAMY Pushing For The Deal?</h2>As per Larvotto’s draft feasibility report on the Hillgrove project, the mine is expected to meet 7% of the world’s antimony requirements after it is fully commissioned. The deal could have helped the combined company tap into the growing demand for the critical mineral amid export restrictions imposed by China.Last month, U.S. Antimony secured a five-year contract worth up to $245 million from the U.S. Defense Logistics Agency to contribute to the antimony stockpile. Earlier in October, it secured $25 million in capital through a securities purchase agreement with a prominent long-only mutual fund to spend on its growth plans.<h2 class="st-heading-2">What Is Retail Thinking?</h2>Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/UAMY">UAMY stock</a> was still in the ‘extremely bullish’ territory late Sunday, with the ticker trending on top.<figure class="image"><img style="aspect-ratio:805/104;" src="https://news.stocktwits-cdn.com/UAMY_Oct_26_JPG_6ba887780a.webp" alt="UAMY’s Sentiment Meter and Message Volume as of 09:45 p.m. ET on Oct. 26, 2025 | Source: Stocktwits" width="805" height="104"><figcaption>UAMY’s Sentiment Meter and Message Volume as of 09:45 p.m. ET on Oct. 26, 2025 | Source: Stocktwits</figcaption></figure>One user wrote that Larvotto executives might have believed they had the stronger hand following the U.S.-Australia agreement on critical minerals.<stembedurl>https://stocktwits.com/tcbntn/message/633773556</stembedurl>“We don’t have to own everything. At the end of the day, both countries need each other; therefore, we will have some sort of deal beneficial to both,” another trader said.<stembedurl>https://stocktwits.com/clostov1919/message/633771910</stembedurl>United States Antimony stock has jumped over sixfold this year. However, the stock’s recent gains could come under threat after U.S. Treasury Secretary Scott Bessent indicated that China might pause its restrictions on rare-earth exports. While antimony is not part of the rare earth group, antimony miners have moved in tandem with rare earth stocks in recent years in response to developments related to China.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/sagimet-biosciences-stock-soars-after-positive-data-for-experimental-drug-in-acne-study/cLGJDmDR3tq">Sagimet Biosciences Stock Soars After Positive Data For Experimental Drug In Acne Study</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the United States Antimony (US Antimony) logo is seen displayed on a smartphone screen.

Australia’s Larvotto Rejects US Antimony Deal Over Valuation Concerns 

The initial offer included a fixed exchange ratio of 6 UAMY common stock shares for every 100 Larvotto shares.

United States Antimony (UAMY) Soars 20.0%: Is Further Upside Left in the Stock?

United States Antimony (UAMY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

United States Antimony (UAMY) stock jumped over 10% in premarket trading on Monday after the company said it has submitted a non-binding offer to acquire Australia’s Larvotto Resources at a valuation of close to $470 million.<h2 class="st-heading-2">What’s The Deal?</h2>The company intends to pay Larvotto shareholders A$1.40 per share to acquire the rest of the company, which it does not own. U.S. Antimony already unveiled a 10% stake in the Australian miner last week.The offer, which was sent to Larvotto on Friday, includes a fixed exchange ratio of 6 USAC common stock shares for every 100 Larvotto shares."Our proposal to combine with Larvotto reflects our deep commitment to build a world-class industry player in the critical minerals space and our strong conviction in the strategic and cultural fit between the two organizations as well as our countries,” said the U.S. firm’s CEO, Gary Evans.<h2 class="st-heading-2">What Does US Antimony Gain?</h2>Larvotto operates the Hillgrove Gold and Antimony Project in New South Wales, Australia, which contains the world’s eighth-largest antimony reserves. The possible deal could help the combined company tap into the growing demand for the critical mineral amid export restrictions imposed by China.Last month, U.S. Antimony secured a five-year contract worth up to $245 million from the U.S. Defense Logistics Agency to contribute to the antimony stockpile. Earlier in October, it secured $25 million in capital through a securities purchase agreement with a prominent long-only mutual fund<h2 class="st-heading-2">Stocktwits Traders Cheer UAMY-Larvotto Deal</h2>Retail sentiment on Stocktwits <a href="https://stocktwits.com/symbol/UAMY">U.S. Antimony</a> was in the 'extremely bullish' territory at the time of writing.United States Antimony stock has surged over sixfold this year, easily outpacing gains on the benchmark S&amp;P 500 and Nasdaq indices.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Currency and Exchange Stock Chart for Finance and Economy Display. (Image Courtesy: Getty Images)

Why Is US Antimony Surging Over 10% Premarket Today? 

The company intends to pay Larvotto shareholders A$1.40 per share to acquire the rest of the company, which it does not own.

The company intends to pay Larvotto shareholders A$1.40 per share to acquire the remaining stake, which it does not own.

Markets Rebound Nicely Ahead of Q3 Earnings Season 

Even though we've seen more than a dozen companies already officially report Q3 earnings results this period, Q3 earnings season really kicks off with the release of earnings from some of the biggest banks on Wall Street.

United States Antimony Corp. (UAMY) on Friday announced that it has secured $25 million in capital through a securities purchase agreement with a prominent long-only mutual fund.&nbsp;The agreement covers the sale of about two million common shares, with the transaction expected to finalize around October 14, pending standard closing conditions.The deal is set to support the company’s ambitions across mineral development and infrastructure upgrades. Following the announcement,&nbsp;<a href="https://stocktwits.com/symbol/UAMY">United States Antimony stock</a> traded over 10% higher in Friday’s premarket. On Stocktwits, retail sentiment around the stock improved to ‘extremely bullish’ from ‘bullish’ territory the previous day amid ‘high’ message volume levels.&nbsp;US Antimony plans to allocate the funds across several strategic initiatives. Among them are plans to boost its inventory of antimony and other critical minerals, expand mineral leaseholds in Alaska and Montana, and explore the possibility of capacity increase at its Madero Smelter in Mexico.Additionally, the company is eyeing potential acquisitions in the critical minerals sector while also setting aside capital for general operational needs."We have now raised a total of $69.25 million in three separate tranches with two large institutions over the last 45 days at increasingly higher share price,” said Chairman and Chief Executive Officer of United States Antimony, Gary C. Evans.The company sells antimony, zeolite, and precious metals primarily in the U.S. and Canada.&nbsp;Last month, the company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/us-antimony-secures-245-m-defense-contract-over-five-years-report/chDhH2ZR35a">secured&nbsp;</a>a five-year contract worth up to $245 million from the U.S. Defense Logistics Agency to contribute to the antimony stockpile.United States Antimony stock has gained over 513% in 2025 and over 1,476% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bristol-myers-squibb-to-acquire-orbital-therapeutics-in-1point5-billion-deal/ch6aDhLR3Sj">Bristol Myers Squibb To Acquire Orbital Therapeutics In $1.5B Deal</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

United States Antimony Stock Surges 10% After Company Secures $25M Capital To Expand Mineral Operations

The securities purchase agreement covers the sale of about two million common shares, with the transaction expected to finalize around October 14.

United States Antimony (UAMY) stock has notched five consecutive sessions of gains amid growing investor optimism around critical mineral firms.Shares of the firm, which operates the only antimony smelters in North America, closed at an all-time high on Thursday after rising over 14% in the regular trading session, following China's imposition of export restrictions on rare earths. While antimony is not part of the rare earth group, it benefited from the positive sentiment.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/UAMY">United States Antimony</a> was in the ‘bullish’ territory at the time of writing, compared with ‘neutral’ a month ago. The stock has seen a 17% uptick in follower count on the social media platform over the past month.<figure class="image"><img style="aspect-ratio:799/82;" src="https://news.stocktwits-cdn.com/UAMY_Oct_10_JPG_204471c1a4.webp" alt="UAMY’s Sentiment Meter and Message Volume as of 12:57 a.m. ET on Oct. 10, 2025 | Source: Stocktwits" width="799" height="82"><figcaption>UAMY’s Sentiment Meter and Message Volume as of 12:57 a.m. ET on Oct. 10, 2025 | Source: Stocktwits</figcaption></figure>Antimony is used in munitions, batteries, military-grade compounds, and the semiconductor industry. However, China controls 65% of global antimony and restricted exports of the critical mineral last year amid its tussle with Washington, D.C. The restrictions have brought United States Antimony into the spotlight as the sole refiner of the metalloid, whose prices have skyrocketed to over $20 per pound from $5 per pound following Beijing’s export ban.CEO Gary Evans said in a Fox Business interview earlier this week that the company could meet the growing U.S. demand within a year or two by ramping up output. Last month, the company secured a five-year contract worth up to $245 million from the U.S. Defense Logistics Agency to contribute to the antimony stockpile.Last week, President Donald Trump signed an executive order to build a key road in Alaska to connect minerals-rich, isolated parts of the state to a highway. The infrastructural development will likely help the firm to ramp up production, as it has already secured claims of over 35,000 acres in Alaska for mining to supply to its smelter in Montana.One user described the stock as undervalued and the critical minerals sector as “red-hot.”<stembedurl>https://stocktwits.com/Painman/message/631744146</stembedurl>“Get in or buy higher tomorrow,” another user said.<stembedurl>https://stocktwits.com/Knowledgeworthmore/message/631755386</stembedurl>The stock has risen over fivefold this year. Investors are now keenly waiting for the start of its Alaska operations following the acquisition of the necessary permits.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-venture-global-stock-plunge-after-hours/ch6alXaR31S">Why Did Venture Global Stock Plunge After-Hours?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

US Antimony Stock On 5-Day Winning Streak — What's Making Investors Bullish?

Shares of the firm, which operates the only antimony smelter in North America, closed at an all-time high on Thursday.

United States Antimony Corp. (UAMY) reportedly said on Tuesday it has secured a five-year contract worth up to $245 million from the U.S. Defense Logistics Agency.According to a Reuters report, the company secured a sole-source contract to supply antimony metal ingots for the defense stockpile.Retail sentiment on the <a href="https://stocktwits.com/symbol/UAMY">stock</a> remained unchanged in the ‘extremely bullish’ territory, with message volumes at ‘high’ levels, according to data from Stocktwits. Shares of the company jumped over 21% in early trading on Tuesday.Since taking office, U.S. President Donald Trump has implemented multiple executive and policy measures to strengthen U.S. access to critical minerals as part of the country’s efforts to maintain national security and economic self-reliance. Reuters noted that Antimony, which is used in munitions, batteries, and military-grade compounds, was flagged as a vulnerability in the U.S. industrial base by defense officials.“It’s incredibly meaningful for all our employees to play such a strategic role in strengthening our nation's defense readiness," USAC CEO Gary C. Evans said, according to Reuters.The report noted that U.S. Antimony Corp operates North America’s only two antimony smelters and is positioned to begin immediate fulfillment from its domestic facilities. Reuters, citing the company, said that the first delivery order is expected this week.Shares of the company have jumped 322% this year and gained nearly 860% in the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/amazon-faces-ftc-in-trial-over-alleged-prime-enrollment/chDhMWHR357">Amazon Faces FTC In Trial Over Alleged Prime Enrollment Strategy: Report</a>

US Antimony Secures $245M Defense Contract Over Five Years: Report

According to a Reuters report, the company secured a sole-source contract to supply antimony metal ingots for the defense stockpile.

Strength Seen in Centrus Energy (LEU): Can Its 12.1% Jump Turn into More Strength?

Centrus Energy (LEU) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

Will Robinhood Markets ($HOOD) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$7.00
Prev Close	$7.04
Open	$6.50
Dividend Yield	0.00%
50-Day Moving Average	$7.91
Beta	1.20
Avg. Volume	23.76M
PE Ratio	-782.22

52-Week High	$19.71
52-Week Low	$0.4901
Market Capitalization	$977.7M
EPS (Annual)	-$0.016
Price to Book	22.38
Revenue Per Employee	$240,934.87
Enterprise Value/EBITDA	N/A

UAMY
United States Antimony Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest UAMY News

UAMYUnited States Antimony Corp